Evidence map›Paper›PMID 39347566›Full record

ArticleCancer research communications2024

Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI.

Jordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, Grace Grimsley, Jennifer R Bethard, Dean A Troyer, Javier Hernandez, Jennifer D Wu, Joseph E Ippolito, Lauren E Ball and 6 more

Abstract read
In one paragraph

Article in Cancer research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jordan P HartigMedical University of South Carolina, Charleston, South Carolina.ORCID 0009-0000-2569-3585
Kaitlyn BejarUniversity of Texas Health Science Center, San Antonio, Texas.ORCID 0000-0002-3911-9290
Lyndsay E A YoungMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-6873-5674
Grace GrimsleyMedical University of South Carolina, Charleston, South Carolina.ORCID 0009-0001-0639-3672
Jennifer R BethardMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-7653-156X
Dean A TroyerEastern Virginia Medical School, Norfolk, Virginia.ORCID 0000-0002-0337-5890
Javier HernandezAudie L. Murphy Memorial Veteran's Administration Hospital, San Antonio, Texas.ORCID 0000-0002-2666-5989
Jennifer D WuNorthwestern Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0002-8925-268X
Joseph E IppolitoWashington University in St. Louis School of Medicine, St. Louis, Missouri.ORCID 0000-0003-1913-5573
Lauren E BallMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-6780-1679
Jonathan A L GelfondUniversity of Texas Health Science Center, San Antonio, Texas.ORCID 0000-0002-0773-3683
Teresa L Johnson-PaisUniversity of Texas Health Science Center, San Antonio, Texas.ORCID 0000-0001-7580-1206
Anand S MehtaMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-9846-9389
Robin J LeachUniversity of Texas Health Science Center, San Antonio, Texas.ORCID 0000-0002-3201-5579
Peggi M AngelMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-4436-555X
Richard R DrakeMedical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-6285-6440

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CAU01CA086402 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEACH, ROBIN JEAN, THOMPSON, IAN M. · 2000 to 2018
$33.1M
Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancerP50CA180995 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., HUSSAIN, MAHA H · 2015 to 2025
$19.9M
Tumor immune and glycan biomarkers for progressive prostate cancerR01CA212409 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., DRAKE, RICHARD R. · 2018 to 2022
$2.7M
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate CancerR01CA258690 · NCI · WASHINGTON UNIVERSITY · PI Joseph Edward Ippolito, Michael Hiroshi Johnson · 2022 to 2026
$2.7M
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approachesR01CA282022 · NCI · WASHINGTON UNIVERSITY · PI Joseph Edward Ippolito, Eric H Kim · 2023 to 2026
$2.4M
CTSA Predoctoral T32 at The University of Texas Health Science Center at San AntonioT32TR004545 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Yong-Hee Patricia Chun, Christopher R. Frei · 2023 to 2026
$1.1M
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and CellsU01CA242096 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANGEL, PEGGI M, DRAKE, RICHARD R. · 2019 to 2021
$818k
NCATS NIH HHS T32 TR004545NCI NIH HHS P30 CA138313NCI NIH HHS P50 CA180995NCI NIH HHS R01 CA212409NCI NIH HHS R01 CA258690NCI NIH HHS R01 CA282022NCI NIH HHS U01 CA086402NCI NIH HHS U01 CA242096
6 · The paper itself

Abstract

significanceUsing matrix-assisted laser desorption/ionization mass spectrometry imaging techniques on a unique cohort of prostate cancer tissues, we highlighted several molecular characteristics of matrix that have potential to act as early predictors of prostate cancer metastasis.

Indexed as

Extracellular Matrix ProteinsPolysaccharidesProstatic NeoplasmsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTissue Array AnalysisCohort StudiesCollagenHumansMaleCollagenExtracellular Matrix ProteinsPolysaccharides

Identifiers

PMID39347566
PMCPMC11600299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.